{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33747847", "DateRevised": {"Year": "2021", "Month": "03", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "07"}], "Language": ["eng"], "ELocationID": ["10.34172/apb.2021.022"], "Journal": {"ISSN": "2228-5881", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Advanced pharmaceutical bulletin", "ISOAbbreviation": "Adv Pharm Bull"}, "ArticleTitle": "Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients.", "Pagination": {"StartPage": "6", "EndPage": "7", "MedlinePgn": "6-7"}, "AuthorList": [{"Identifier": ["0000-0001-9755-9422"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Mahmoudi", "ForeName": "Javad", "Initials": "J"}, {"Identifier": ["0000-0003-2872-1072"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Sadigh-Eteghad", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": ["0000-0001-9030-2106"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Evidence-Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Salehi-Pourmehr", "ForeName": "Hanieh", "Initials": "H"}, {"Identifier": ["0000-0003-1791-9120"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Gharekhani", "ForeName": "Afshin", "Initials": "A"}, {"Identifier": ["0000-0002-9725-3033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran."}], "LastName": "Ziaee", "ForeName": "Mojtaba", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Iran", "MedlineTA": "Adv Pharm Bull", "NlmUniqueID": "101578021", "ISSNLinking": "2228-5881"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hsu LY, Lee CC, Green JA, Ang B, Paton NI, Lee L. et al. Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003;9(6):713\u20137. doi: 10.3201/eid0906.030264.", "ArticleIdList": ["10.3201/eid0906.030264", "PMC3000162", "12781012"]}, {"Citation": "Eifan SA, Nour I, Hanif A, Zamzam AMM, AlJohani SM. A pandemic risk assessment of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia. Saudi J Biol Sci. 2017;24(7):1631\u20138. doi: 10.1016/j.sjbs.2017.06.001.", "ArticleIdList": ["10.1016/j.sjbs.2017.06.001", "PMC5643837", "29062261"]}, {"Citation": "Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W. et al. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812\u2013827 e19. doi: 10.1016/j.cell.2020.06.043.", "ArticleIdList": ["10.1016/j.cell.2020.06.043", "PMC7332439", "32697968"]}, {"Citation": "Ghahestani SM, Mahmoudi J, Hajebrahimi S, Sioofy-Khojine AB, Salehi-Pourmehr H, Sadeghi-Ghyassi F. et al. Bradykinin as a probable aspect in SARS-Cov-2 scenarios: is bradykinin sneaking out of our sight? Iran J Allergy Asthma Immunol. 2020;19(S1):13\u20137. doi: 10.18502/ijaai.v19i(s1.r1).2850.", "ArticleIdList": ["10.18502/ijaai.v19i(s1.r1).2850", "32534506"]}, {"Citation": "Nejadi Babadaei MM, Hasan A, Vahdani Y, Haj Bloukh S, Sharifi M, Kachooei E. et al. Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase. J Biomol Struct Dyn. 2020:1\u20139. doi: 10.1080/07391102.2020.1767210.", "ArticleIdList": ["10.1080/07391102.2020.1767210", "PMC7256352", "32397906"]}, {"Citation": "Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z. et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives experience of clinical immunologists from China. Clin Immunol. 2020;214:108393. doi: 10.1016/j.clim.2020.108393.", "ArticleIdList": ["10.1016/j.clim.2020.108393", "PMC7102614", "32222466"]}, {"Citation": "Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155\u201366. doi: 10.1038/s41584-020-0372-x.", "ArticleIdList": ["10.1038/s41584-020-0372-x", "32034323"]}, {"Citation": "Stokkermans TJ, Goyal A, Bansal P, Trichonas G. Chloroquine and Hydroxychloroquine Toxicity. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020.", "ArticleIdList": ["30725771"]}, {"Citation": "Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020;71(15):732\u20139. doi: 10.1093/cid/ciaa237.", "ArticleIdList": ["10.1093/cid/ciaa237", "PMC7108130", "32150618"]}, {"Citation": "Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105949", "PMC7102549", "32205204"]}, {"Citation": "Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today\u2019s diseases? Lancet Infect Dis. 2003;3(11):722\u20137. doi: 10.1016/s1473-3099(03)00806-5.", "ArticleIdList": ["10.1016/s1473-3099(03)00806-5", "PMC7128816", "14592603"]}, {"Citation": "Wang B, Guo H, Ling L, Ji J, Niu J, Gu Y. The chronic adverse effect of chloroquine on kidney in rats through an autophagy dependent and independent pathways. Nephron. 2020;144(2):96\u2013108. doi: 10.1159/000503882.", "ArticleIdList": ["10.1159/000503882", "31661702"]}, {"Citation": "Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829\u201338. doi: 10.1016/j.kint.2020.03.005.", "ArticleIdList": ["10.1016/j.kint.2020.03.005", "PMC7110296", "32247631"]}, {"Citation": "Zhuang MW, Cheng Y, Zhang J, Jiang XM, Wang L, Deng J. et al. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. J Med Virol. 2020 doi: 10.1002/jmv.26139.", "ArticleIdList": ["10.1002/jmv.26139", "PMC7300907", "32497323"]}, {"Citation": "Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193\u20134. doi: 10.1007/s11255-020-02451-9.", "ArticleIdList": ["10.1007/s11255-020-02451-9", "PMC7103107", "32222883"]}, {"Citation": "Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219\u201327. doi: 10.1016/j.kint.2020.04.003.", "ArticleIdList": ["10.1016/j.kint.2020.04.003", "PMC7194105", "32327202"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "20"}, {"Year": "2020", "Month": "7", "Day": "8"}, {"Year": "2020", "Month": "7", "Day": "15"}, {"Year": "2021", "Month": "3", "Day": "22", "Hour": "8", "Minute": "20"}, {"Year": "2021", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "11", "Day": "7"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33747847", "PMC7961219", "10.34172/apb.2021.022"]}}], "PubmedBookArticle": []}